Literature DB >> 1875120

Heterogeneity in ploidy and S-phase fraction in colorectal adenocarcinomas.

G Lindmark1, B Glimelius, L Påhlman, P Enblad.   

Abstract

The heterogeneity in the DNA content was analysed in multiple biopsies from the surgical specimens in 77 cases of colonic and 46 cases of rectal adenocarcinomas. Frozen and unfixed tumour tissue was analysed with the flow cytometric technique. A total of 78/123 (63%) of all tumours displayed aneuploid stemlines in one or more pieces of tumour tissue; 45 were homogeneously aneuploid and 33 were heterogeneous, presenting both aneuploid and near-diploid samples. The remaining 45 tumours were homogeneously near-diploid. The heterogeneity in ploidy tended to be slightly higher if ten as compared with four samples from each tumour were analysed. Ploidy correlated to localization in the bowel and gender, but not to age, histopathological tumour stage, tumour differentiation or to the resectability rate for cure. The mean value of the S-phase fraction was 17% (range 7-31%) in the near-diploid and 14% (range 8-20%) in the aneuploid tumours. The range of the intratumoural variation was small for the DNA index (at most 5%) and high for the S-phase fraction (19% for near-diploid and 24% for aneuploid tumour pieces). Neither the mean value nor the heterogeneity in the DNA index and in the S-phase fraction displayed any correlation with the studied characteristics. In conclusion, the ploidy and the S-phase fraction varied considerably both within and between the tumours. As a consequence, multiple sampling is mandatory for a correct classification of colorectal adenocarcinomas based on the DNA content.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1875120     DOI: 10.1007/bf00300207

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  45 in total

Review 1.  [Flow cytometry. Application to the study of cellular content of DNA in colorectal tumors].

Authors:  T Sano; Y Remvikos; R J Salmon
Journal:  Gastroenterol Clin Biol       Date:  1988 Aug-Sep

2.  Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study.

Authors:  D J Jones; M Moore; P F Schofield
Journal:  Br J Surg       Date:  1988-01       Impact factor: 6.939

3.  Value of flow cytometric determination of ploidy as a guide to prognosis in operable rectal cancer: a multivariate analysis.

Authors:  H S Goh; J R Jass; W S Atkin; J Cuzick; J M Northover
Journal:  Int J Colorectal Dis       Date:  1987-02       Impact factor: 2.571

4.  Prognostic value of DNA content in colorectal carcinoma. A flow cytometric study with some methodologic aspects.

Authors:  S O Emdin; R Stenling; G Roos
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

5.  Neoadjuvant (preoperative) chemotherapy for breast cancer.

Authors:  J Ragaz; R Baird; P Rebbeck; J Goldie; A Coldman; J Spinelli
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

6.  Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas.

Authors:  P Quirke; M F Dixon; A D Clayden; P Durdey; J E Dyson; N S Williams; C C Bird
Journal:  J Pathol       Date:  1987-04       Impact factor: 7.996

7.  DNA ploidy, tumour site, and prognosis in colorectal cancer. A flow cytometric study of paraffin-embedded tissue.

Authors:  T B Halvorsen; E Johannesen
Journal:  Scand J Gastroenterol       Date:  1990-02       Impact factor: 2.423

8.  Predictive assays for the therapy of rectum carcinoma.

Authors:  C Streffer; D van Beuningen; E Gross; J Schabronath; F W Eigler; A Rebmann
Journal:  Radiother Oncol       Date:  1986-04       Impact factor: 6.280

9.  Survival of large bowel carcinoma patients with different DNA ploidy.

Authors:  T O Rognum; E Thorud; E Lund
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

10.  Is DNA aneuploidy a good prognostic indicator in patients with advanced colorectal cancer?

Authors:  P J Finan; P Quirke; M F Dixon; J E Dyson; G R Giles; C C Bird
Journal:  Br J Cancer       Date:  1986-08       Impact factor: 7.640

View more
  5 in total

1.  Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer.

Authors:  R Palmqvist; A Oberg; C Bergström; J N Rutegård; B Zackrisson; R Stenling
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

2.  Stromal tenascin distribution as a prognostic marker in colorectal cancer.

Authors:  U Kressner; G Lindmark; B Tomasini-Johansson; R Bergström; B Gerdin; L Påhlman; B Glimelius
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer.

Authors:  G Lindmark
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

4.  Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers.

Authors:  R Palmqvist; P Sellberg; A Oberg; B Tavelin; J N Rutegård; R Stenling
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

5.  Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer.

Authors:  M S Wilson; C M West; G D Wilson; S A Roberts; R D James; P F Schofield
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.